Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology

Neutropenia Clinical Trials

A listing of Neutropenia medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 Last 

Florida

Research- Hen/Onc Associates of the Treasure Coast
Port St. Lucie Florida 34952

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda Maryland 20892

Patients are needed to participate in a clinical research study of Clofarabine and Lenalidomide

New York

Memorial Sloan-Kettering Cancer Center
New York New York 10065

A Phase 4 clinical study for patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Tennessee

Associates in Oncology & Hematology
Chattanooga Tennessee 37421

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Texas

The University of Texas, Health Science Center at San Antonio
San Antonio Texas 78229

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

China

Cancer Institute and Hospital, CAMS
Beijing

A clinical research study of pegfilgrastim,30mcg/kg, pegfilgrastim, 60mcg/kg, pegfilgrastim, 100mcg/kg and filgrastim, 5mcg/kg for the treatment of Neutropenia

Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing Beijing 100021

Patients are needed to participate in a clinical research study evaluating Pegfilgrastim for the treatment of Neutropenia

Beijing Cancer Hospital
Beijing 100142

Patients are needed to participate in a clinical research study of rHSA/GCSF to evaluate Underdose (Unintentional), Cancer or Tumor

Cancer Institute and Hospital, CAMS
Beijing

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Shanghai Pulmonary Hospital
Shanghai Shanghai 200433

A Phase 3 clinical study for patients with NSCLC, Neutropenia or Febrile Neutropenia

View More »

Tianjin Medical University Cancer Institute and Hospital
Tianjin Tianjin 300060

Patients are needed to participate in a clinical research study evaluating GW003 for the treatment of Chemotherapy-induced Neutropenia or Metastatic Tumors

Czech Republic

Research Site
Praha 10 100 34
Updated

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Nemocnice Znojmo
Znojmo 66902

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

France

Hôpital Européen Georges Pompidou - Service Oncologie Médicale
Paris 75908

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Germany

Teva Investigational Site 32284
Aurich

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Teva Investigational Site 32277
Berlin

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

University Hospital Cologne
Cologne NRW 50937

A clinical research study of 3M Tegaderm IV securement dressing for the treatment of Catheter-related Bloodstream Infection

Teva Investigational Site 32269
Dresden

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Teva Investigational Site 32276
Frechen

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

View More »

Universitaetsklinik Hamburg-Eppendorf, Med. Klinik II Onkologie, Haematologie
Hamburg 20246

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

MHH
Hannover

A clinical research study of Eligible patients will be treated with Zarzio for the treatment of Severe Chronic Neutropenia

Teva Investigational Site 32270
Herne

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Teva Investigational Site 32275
Köln

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Teva Investigational Site 32281
Mülheim a. R.

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Teva Investigational Site 32288
Stolberg

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Research Site
Troisdorf 53840
Updated

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Italy

Azienda Ospedaliero Universitaria "San Giovanni Battista di Torino"
Torino 10126

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Japan

Nagoya University Graduate School of Medicine
Nagoya 466-8550

A clinical trial seeking patients for a research study for the treatment of Febrile Neutropenia

Korea, Republic of

Busan

Patients are needed to participate in a clinical research study of Micafungin to evaluate Neutropenia, Hematopoietic Stem Cell Transplantation or Invasive Fungal Disease

Daegu

Patients are needed to participate in a clinical research study of Micafungin to evaluate Neutropenia, Hematopoietic Stem Cell Transplantation or Invasive Fungal Disease

Daejeon

Patients are needed to participate in a clinical research study of Micafungin to evaluate Neutropenia, Hematopoietic Stem Cell Transplantation or Invasive Fungal Disease

Goyang

Patients are needed to participate in a clinical research study of Micafungin to evaluate Neutropenia, Hematopoietic Stem Cell Transplantation or Invasive Fungal Disease

Hwasun

Patients are needed to participate in a clinical research study of Micafungin to evaluate Neutropenia, Hematopoietic Stem Cell Transplantation or Invasive Fungal Disease

View More »

Seoul

Patients are needed to participate in a clinical research study of Micafungin to evaluate Neutropenia, Hematopoietic Stem Cell Transplantation or Invasive Fungal Disease

Suwon

Patients are needed to participate in a clinical research study of Micafungin to evaluate Neutropenia, Hematopoietic Stem Cell Transplantation or Invasive Fungal Disease

Poland

Bydgoszcz

Patients are needed to participate in a clinical research study evaluating Maxy-G34 for the treatment of Chemotherapy-Induced Neutropenia or Breast Cancer

Gdansk

Patients are needed to participate in a clinical research study evaluating Maxy-G34 for the treatment of Chemotherapy-Induced Neutropenia or Breast Cancer

Research Site
Gdynia 81-519
Updated

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Research Site
Koszalin 75-581
Updated

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

SPSK1 Klinika Hematologii
Lublin 20-081

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

View More »

Lublin

Patients are needed to participate in a clinical research study evaluating Maxy-G34 for the treatment of Chemotherapy-Induced Neutropenia or Breast Cancer

Research Site
Warszawa 02-097
Updated

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Romania

Centrul de Diagnostic si Tratament Euromedic Fundeni
Bucuresti 022328

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Jud. Bacau

Patients are needed to participate in a clinical research study evaluating Maxy-G34 for the treatment of Chemotherapy-Induced Neutropenia or Breast Cancer

Suceava

Patients are needed to participate in a clinical research study evaluating Maxy-G34 for the treatment of Chemotherapy-Induced Neutropenia or Breast Cancer

Timisoara

Patients are needed to participate in a clinical research study evaluating Maxy-G34 for the treatment of Chemotherapy-Induced Neutropenia or Breast Cancer

Russian Federation

Moscow Area

Patients are needed to participate in a clinical research study evaluating Maxy-G34 for the treatment of Chemotherapy-Induced Neutropenia or Breast Cancer

Spain

Hospital Clinic i Provincial de Barcelona
Barcelona 08036

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Sweden

Karolinska Institut
Stockholm

A clinical research study of Eligible patients will be treated with Zarzio for the treatment of Severe Chronic Neutropenia

First 1 2 Last